Completed PHASE2 INTERVENTIONAL NCT00135720
Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris
A Double-Blinded, Placebo-Controlled Study of Etanercept (Enbrel) in the Treatment of Pemphigus Vulgaris
Sponsor: Brigham and Women's Hospital
Conditions
Pemphigus Vulgaris
Interventions
Enbrel (Etanercept)
Updated 1 time since 2024 Last updated: Jun 2, 2015 Started: Jun 30, 2004 Completion: Nov 30, 2007
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
This PHASE2 trial investigates Pemphigus Vulgaris and is currently completed. Brigham and Women's Hospital leads this study, which shows 1 recorded version since 2004 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
1 version recorded Completed — PHASE2
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Brigham and Women's Hospital
- Massachusetts General Hospital
- Stanford University
Data source: Massachusetts General Hospital
For direct contact, visit the study record on ClinicalTrials.gov .